Killer fungus forecast to spread to UK as climate changes
A killer fungus that infects millions of people a year in hotter climes may soon spread through Europe and into the UK as the world warms further, according to a new study on how climate change spreads disease.
The aspergillus species - which can cause deadly human brain infections, spoil livestock and render crops unsafe to eat - is forecast to spread northwards from Africa and South America into Europe and Asia.
How far it spreads will depend on how quickly the world phases out fossil fuels and other drivers of climate change, the paper said, while slow action will put more people at risk.
Global warming is also raising the risk of the spread of other diseases, such as those spread by mosquitoes like malaria and dengue.
Fungi are a growing concern but largely unexplored.
They live in the air, soil and inside our bodies and spread through spores in the air we breathe - but more than 90% are estimated still to be unknown to science.
Lead author of the new research, Norman van Rhijn from Manchester University, told Sky News they are "extremely difficult" to treat.
Few antifungal medicines exist, while the fungi themselves are increasingly drug-resistant and hard to spot and diagnose.
Fungi are also essential to a healthy ecosystem, decomposing organic matter and helping to suck up climate-heating carbon dioxide.
1:55
'Scary' reality
Viewers of the TV show The Last of Us will be familiar with the threat: the post-apocalyptic drama depicts a brain-altering fungus that has wiped out much of society.
But "reality is already scary enough", Dr Van Rhijn told Sky News presenter Leah Boleto.
Infections from all fungi already cause 2.5 million deaths globally each year.
Healthy immune systems kick out the spores, but vulnerable people can end up contracting infections like invasive aspergillosis, which spreads rapidly from the lungs to other parts of the body like the brain, and currently kills 1.8m people a year globally.
"Most fungi live in the environment," said Dr Van Rhijn. "Because that environment is rapidly changing, we will definitely see different kinds of diseases and infections popping up over the next 50 years or so."
The scientists looked at the existing habitats suitable for certain types of fungi to grow. They then mapped how those habitats might move or spread under different rates of global warming.
In a worst-case scenario, the spread of Aspergillus flavus could increase by about 16%, putting 1 million more people at risk of infection in Europe, damaging the respiratory system, as well as various crops.
It is highly virulent, causes severe infections and is resistant to many antifungals available.
And another in the same family, Aspergillus fumigatus, could spread by a further 77%, potentially exposing nine million people in Europe, the research suggested.
However, it also found temperatures in Africa could become so high that some fungi would no longer be able to survive on the continent.
The study has not yet been peer-reviewed, but is backed by the renowned health institution the Wellcome Trust, which funded the research.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
35 minutes ago
- BBC News
Canterbury GP's genital exams 'unnecessary', court hears
A former GP conducted "unnecessary" genital examinations on nine male patients, including young teenagers, a court has Manson, 56, is alleged to have carried out the exams for complaints including coughs, headaches and knee accusers said they did not recall him wearing gloves, offering a chaperone or giving "proper explanations" for the examinations before they took at Canterbury Crown Court on Monday, Dr Manson, of Tower Way, Canterbury, denied 18 offences of sexual assault and six of indecent assault. The court heard that Dr Manson worked as a GP between 1994 and 2017, along with working as a GP trainer and programme director of GP training, and as a GP appraiser for the General Medical first complaint of sexual assault against him was filed to Canterbury Police in 2017, followed by an NHS England exercise which saw more alleged victims come a police interview, he said he had never touched a patient for improper or sexual purposes and said every examination was conducted for justified medical reasons, the court was Jennifer Knight KC told jurors Manson also failed to document in patients' notes any potential findings or the the fact such examinations had taken place at all. The first two alleged victims were brothers and both saw Manson before and after they were 16, the court said they were told to pull down their trousers and boxer shorts during a number of Knight said that the elder brother initially "assumed" this was necessary but had gradually become "uncomfortable".Their mother told investigators she never met Dr Manson when her sons were young teenagers as she would always stay in the waiting room, the court heard. Another alleged victim saw Dr Manson twice in 1999 when he was 35 and then 12 years later in 2011, each time with abdominal all three occasions, a genital examination was undertaken and, on both occasions in 1999, his underwear was removed without consent, the court Manson told police this had been necessary to check lymph nodes and femoral pulses in the victim's groin area. However, Ian Wall, a forensic medicine professor and GP, noted there would be no reason to do this, especially without trial continues.
The Sun
40 minutes ago
- The Sun
The 52p herb that could help prevent Alzheimer's – plus 3 other ways it can benefit your health
KNOWN for its strong, pine-like flavour and its use in various dishes, rosemary has a lot more going for it than its scent and taste. The popular herb is starting to gain recognition for its impressive health benefits, especially when it comes to brain health, inflammation and immune function. And research published this year suggests it could even help in the fight against Alzheimer's disease - the leading cause of dementia worldwide. Rosemary has previously been linked to memory and mental clarity. In ancient Greece and Rome, students and scholars used rosemary to sharpen concentration and recall, says Dipa Kamdar, senior lecturer in pharmacy practice at Kingston University. Writing for The Conversation, she explains: "Modern science is finding there may have been something in this: in one study, people who inhaled rosemary's scent performed better on memory takes compared to those in an unscented environment." There are several ways rosemary benefits the brain, says Kamdar. Firstly, it stimulates blood circulation, including to the brain, helping deliver more oxygen and nutrients, which may improve mental clarity. It also has calming properties, with some studies suggesting its aroma can reduce anxiety and improve sleep - lower stress means better focus and memory retention. Kamdar adds: "Rosemary contains compounds that interact with the brain's neurotransmitters. One such compound, 1,8-cineole, helps prevent the breakdown of acetylcholine, a brain chemical essential for learning and memory. By preserving acetylcholine, rosemary may help support cognitive performance, especially as we age." And rosemary's antioxidants may also help protect brain cells from damage caused by oxidative stress - which is a major factor in cognitive decline. Kamdar says: " Rosemary is rich in phytochemicals, plant compounds with health-enhancing effects. One of the most powerful is carnosic acid, an antioxidant and anti-inflammatory agent that helps shield brain cells from harm, particularly from the kinds of damage linked to Alzheimer's disease." Five simple tests that could indicate dementia What are rosemary's benefits beyond brain health? 2 As well as boosting brain health, studies suggest rosemary may aid digestion by stimulating the liver to produce bile, which helps the body digest fat. In a study with mice, it was shown to reduce inflammation in the digestive tract, potentially aiding in the management of IBS and other inflammatory bowel ailments. And rosemary supplementation may also positively impact the gut microbiota, increasing beneficial bacteria like Bifidobacterium and Bacteroidetes, while reducing harmful bacteria like Escherichia coli. Rosemary may also be able to improve immune function. Some studies, particularly in vitro and animal models, suggest that rosemary and its active compounds, like carnosic acid and rosmarinic acid, can influence immune function. Other studies have shown rosemary may promote immune cell activity, such as increasing antibody production or enhancing the activity of immune cells like dendritic cells. Finally, rosemary could prevent certain cancers. lung, prostate, liver, and breast. Carnosic acid appears to be the plant's primary anticancer component, as it was found in one study to exhibit antiproliferative effects in cancer cells. Compared to speciality herbs or spices, rosemary is considered a relatively affordable herb - just 52p for a 20g packet from Sainsbury's. Other ways to reduce your Alzheimer's risk Be physically active Regular physical activity is crucial for overall health and may help reduce the risk of dementia, including Alzheimer's disease. Aim for at least 150 minutes of moderate-intensity activity per week. Eat a healthy diet A balanced diet, potentially including the Mediterranean diet, can help reduce your risk of dementia, as well as other health conditions. Stay mentally active Keeping your mind active can strengthen your brain's ability to cope with disease. Engage in activities like reading, learning new skills, or playing brain games. Manage other health conditions Maintaining healthy blood pressure, cholesterol, and blood sugar levels can also contribute to reducing your risk of dementia. Prioritise sleep Aim for seven to eight hours of quality sleep each night, as sleep deprivation can negatively impact brain health. Maintain good heart health Taking care of your heart health, including avoiding smoking and excessive alcohol consumption, can also lower your risk of dementia and other diseases. Seek medical advice If you have any concerns about your health or a family history of Alzheimer's, consult with a healthcare professional.
Daily Mail
44 minutes ago
- Daily Mail
Why living until you're 200 really isn't a pipe dream
The idea of living for hundreds of years was once thought to be the pipe dream of billionaires and tech moguls. But scientists at the forefront of anti-ageing research believe they are on the cusp of developing a pill that could lead to people living to the age of 200 and beyond. Medical advances in the last century have led to humans in wealthy nations living into their 80s, almost double the average life expectancy at the turn of the 20th century. Improved nutrition, clean water, better sanitation and huge leaps in medicine have been key in prolonging human life. The oldest known person — the Frenchwoman Jeanne Calment, who sold canvases to Vincent Van Gogh when she was a girl in the late 1800s — lived to the age of 122, dying in 1997. There is some debate about whether humans can naturally live much beyond that age, but it is hoped that science will take human lifespans beyond what is currently thought possible. Dr Andrew Steele, a British computational biologist and author of a new book on longevity, told MailOnline there is no biological reason humans can't reach the age of 200. He believes the big breakthrough will come in the form of drugs that remove 'zombie cells' in the body, which are thought to be one of the main culprits of tissue and organ decay as we age. Pills that flush these cells out of the body are already in human trials in and could be on the market in as little as 10 years, according to Dr Steele, who believes someone reading this could make it to 150 with the help of the drugs. Another field in particular that piques the interest of anti-ageing scientists is the study of DNA of reptiles and other cold-blooded animals. Michigan State University experts have begun studying dozens different types of long-living reptiles and amphibians — including crocodiles, salamanders and turtles that can live as long as 120 years. The team hope they will uncover 'traits' that can also be targeted in humans. Some experts think that eradicating the big killers — cancer, dementia and heart disease — could be the true key to longevity. Dr Steele, the author of Ageless: The New Science of Getting Older Without Getting Old, told MailOnline: 'I don't think there is any kind of absolute cap on how long we can live. 'Studies come out every few years that propose some kind of fundamental limit on human lifespan, but they're always missing one crucial piece: we've never tried treating the ageing process before. 'I can't see physical or biological reason why people couldn't live to 200 — the challenge is whether we've can develop the biomedical science to make it possible.' Other experts believe humans could live to 150 naturally, if it wasn't for chronic illnesses, including Dr Peter Fedichev, a Russian molecular physicist who runs a biomedical AI firm Gero. His company has been studying the genetic data of 500,000 Britons in pursuit of the firm's goal of 'hacking ageing', as they call it. Researchers at Gero made use of an instrument, called DOSI (dynamic organism state indicator), that takes into account age, illness and lifestyle factors, to work out how resilient the body is, including its ability to recover from injury or disease. Using mathematical models, it calculated the maximum age the body — if not altered by drugs or gene therapy — can still recover from is between 120 and 150. The findings were revealed in a study published in the journal Nature Communications last year. But Dr Fedichev warned life extension without improving life quality would be pointless because extremely elderly people would be frail, and prone to illness, meaning new drugs will be vital in the quest for eternal youth. He told MailOnline: 'Such life extension would increase their lifespan past the end of their health span and thus reduce their quality of life. 'Only addressing the root causes of ageing may help bring humans closer to negligibly senescent animals, intercept aging and increase our productive lifespan by a hundred years or more. 'That is why we are calling on a refocusing of our attention from diseases to ageing, from incremental to more radical solutions using those slow-aging animals as inspiration.' Dr Steele says new advances in senolytics could extend life span and quality. Senescent cells — dubbed 'zombie cells' — are cells that eventually stop dividing, then accumulate, releasing compounds in the body that accelerate ageing. Experts believe younger people with healthy immune systems are better able to clear the damaged cells, but as people age, they aren't removed as effectively and they accumulate causing potential problems. Dr Steele said if you put a human cell in a petri dish, it would divide around 50 times before stopping, whereas a Galapagos tortoise — which can live for up to 120 years — sees its cells divide more than 100 times. Studying these sorts of long-living reptiles can help researchers understand more about the way human cells age. Since the 1960s, scientists have known that, as we age, we accumulate ever-greater numbers of these cells, but it wasn't clear if they were just a product of ageing or whether they caused it. The breakthrough came in 2016 when scientists found removing the cells from mice, typically with a short lifespan and plagued with a range of age-related conditions, by injecting them with a synthetic drug called AP20187 extended their life by up to 35 per cent — suggesting senescence was behind ageing itself. Since then, there have been a number of studies confirming the importance of such cells in the ageing process. In 2019, research in the journal Aging Cell showed that old mice pre-treated with Navitoclax, an experimental anti-cancer drug that kills senescent cells, recovered at similar rates to younger mice from an induced heart attack, raising the prospect of a new type of treatment for people with heart conditions. Another study, published in the journal EMBO, demonstrated that clearing out senescent cells from the hearts of mice also reduced symptoms of ageing, such as enlargement and thickening of the walls of the heart muscles. Senolytic drugs are now being safety tested in humans and have attracted investment from several billionaires, including Amazon founder Jeff Bezos and PayPal co-founder Peter Thiel. Dr Steele said: 'Scientists have given these drugs to mice, and they basically get biologically younger: they live longer, get less cancer and heart disease, are less frail — they can run further and faster on the tiny mouse-sized treadmills used in these experiments — and, honestly, they just look great, with plumper skin and thicker fur. 'What this shows us is that tackling the hallmarks of ageing can affect the whole ageing process, from disease risk to the cosmetic stuff, and can do so preventatively — this is the holy grail of anti-ageing medicine.' Both Bezos and Thiel are investors in Unity Biotechnology, which carried out the first human trial of one such drug, aimed at tackling moderate-to-severe osteoarthritis of the knee, in 2019. In the phase one trial, 78 patients were divided into two groups: one was given a dummy drug, while the other was injected in the knee with a drug codenamed UBX0101, which interferes with two proteins in the body, leading to the elimination of senescent cells. The study was a success, with UBX0101 'well-tolerated' by the treated patients, who, after a single injection, had experienced 'improvement in several clinical outcomes, including pain and function'. However, the company faced a setback in 2020 when results from the bigger phase 2 trial found no statistically significant difference between UBX0101 and the placebo groups. Now, the company is trialling a new drug called UBX1325, which has been designed to combat age-related blindness on 46 adults. Dr Steele said it only took one trial to be a success to make a breakthrough in the field of anti-ageing. He told MailOnline: 'We might get unlucky and none of this works but, if it does, every development gives us longer to make the next one, and the first 150-year-old could be someone who's reading this.' Last week, Michigan State University researchers announced they are studying 77 reptiles and amphibians with the hope of understanding what allows them to be so resilient. But they have yet to pinpoint any potential longevity targets, meaning a true breakthrough could still be years off. Dr Alex Zhavoronkov, a biotechnology expert and physicist, said studying animals — particularly those as distantly related to humans as reptiles — has rarely resulted in breakthroughs. He believes scientists are better placed focusing their efforts on studying ageing in real people, and, in particular, technology. Implant chips that use electrodes in the brain to ward off illnesses like Parkinson's are currently being trialled on people. Southmead Hospital in Bristol is believed to be the first in the world to implant the tiny deep brain stimulation (DBS) device when it launched its trial in April. The device works by delivering electrical impulses to damaged areas of the brain. Dr Zhavoronkov said: 'Many years from now humans will be able to control the biology of aging and many other converging technologies will not only return the lost functions but likely augment our capabilities — as you have seen with the glasses, cars, cell phones, the internet, and robotics. 'Advanced technologies starting from dual-purpose pharmaceuticals — drugs that target fundamental aging pathways and age-associated diseases and are trackable with aging biomarkers, which my team is focusing on— to cell and gene therapy and advances in regenerative medicine, implantables, and augmentation of human function with AI and robotics will allow us to dramatically increase life.
